top of page
Pipeline
Pipeline
1. Structure based design approach for developing RNA modulatory compounds
2. Pre-cancer and cancer stem cell organoid bioreactor platforms for inhibitor screening
3. Hematopoietic stem cell bioreactor platform for therapeutic index and stem cell expansion assays
Other ADAR1 inhibitory strategies are under development
Aspera
Biomedicines
bottom of page